Krystal Biotech Long Term Deferred Charges (Quarterly) Analysis

Krystal Biotech, Inc. (KRYS)

261.80 -0.87 (-0.33%) USD | NASDAQ | Feb 20, 16:00

261.90 +0.10 (+0.04%) After-Hours: 20:00

View Long Term Deferred Charges (Quarterly) for KRYS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Charges (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Charges (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Charges (Quarterly) Benchmarks

Start Trial

Amicus Therapeutics, Inc.	--
DexCom, Inc.	--
Alkermes Plc	--
Regeneron Pharmaceuticals, Inc.	--
Alnylam Pharmaceuticals, Inc.	--